Moreover, 3 out of 11 tumors were already 2+/3+ for p130Cas at first diagnosis of breast cancer and they retained this high p130Cas positivity after trastuzumab treatment (Figure 6D). This evidence concerns the gene BCAR1 and breast cancer.